US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4452773A
(en)
|
1982-04-05 |
1984-06-05 |
Canadian Patents And Development Limited |
Magnetic iron-dextran microspheres
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
US4795698A
(en)
|
1985-10-04 |
1989-01-03 |
Immunicon Corporation |
Magnetic-polymer particles
|
US4777239A
(en)
|
1986-07-10 |
1988-10-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Diagnostic peptides of human papilloma virus
|
IN165717B
(fr)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
ATE114507T1
(de)
|
1988-12-28 |
1994-12-15 |
Stefan Miltenyi |
Verfahren sowie materialien zur hochgraduierten magnetischen abspaltung biologischer materialien.
|
US5283173A
(en)
|
1990-01-24 |
1994-02-01 |
The Research Foundation Of State University Of New York |
System to detect protein-protein interactions
|
US5200084A
(en)
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
JP3150340B2
(ja)
|
1990-11-13 |
2001-03-26 |
イムネクス コーポレイション |
二機能選択可能融合遺伝子
|
DE4228458A1
(de)
|
1992-08-27 |
1994-06-01 |
Beiersdorf Ag |
Multicistronische Expressionseinheiten und deren Verwendung
|
AU6953394A
(en)
|
1993-05-21 |
1994-12-20 |
Targeted Genetics Corporation |
Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
|
US6140466A
(en)
|
1994-01-18 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
AU704601B2
(en)
|
1994-01-18 |
1999-04-29 |
Scripps Research Institute, The |
Zinc finger protein derivatives and methods therefor
|
US6007988A
(en)
|
1994-08-20 |
1999-12-28 |
Medical Research Council |
Binding proteins for recognition of DNA
|
GB9824544D0
(en)
|
1998-11-09 |
1999-01-06 |
Medical Res Council |
Screening system
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
WO1996013593A2
(fr)
|
1994-10-26 |
1996-05-09 |
Procept, Inc. |
Recepteurs de lymphocites t monocatenaires solubles
|
WO1996018105A1
(fr)
|
1994-12-06 |
1996-06-13 |
The President And Fellows Of Harvard College |
Recepteur de lymphocyte t monocatenaire
|
US5789538A
(en)
|
1995-02-03 |
1998-08-04 |
Massachusetts Institute Of Technology |
Zinc finger proteins with high affinity new DNA binding specificities
|
GB9603256D0
(en)
|
1996-02-16 |
1996-04-17 |
Wellcome Found |
Antibodies
|
DE19608753C1
(de)
|
1996-03-06 |
1997-06-26 |
Medigene Gmbh |
Transduktionssystem und seine Verwendung
|
US6451995B1
(en)
|
1996-03-20 |
2002-09-17 |
Sloan-Kettering Institute For Cancer Research |
Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
|
US5925523A
(en)
|
1996-08-23 |
1999-07-20 |
President & Fellows Of Harvard College |
Intraction trap assay, reagents and uses thereof
|
GB9710807D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
PT994903E
(pt)
|
1997-06-24 |
2005-10-31 |
Genentech Inc |
Metodos e composicoes para glicoproteinas galactosiladas
|
ATE533784T1
(de)
|
1997-10-02 |
2011-12-15 |
Altor Bioscience Corp |
Lösliche, einzelkettige proteine des t- zellrezeptors
|
US6183746B1
(en)
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
CA2307166A1
(fr)
|
1997-10-31 |
1999-05-14 |
Genentech, Inc. |
Compositions renfermant des glycoformes de glycoproteine et methodes afferentes
|
PT1038022E
(pt)
|
1997-12-12 |
2005-11-30 |
Digene Corp |
Avaliacao de doencas relacionadas com o virus papiloma humano
|
JP4334141B2
(ja)
|
1998-04-20 |
2009-09-30 |
グリカート バイオテクノロジー アクチェンゲゼルシャフト |
抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作
|
CN1249229C
(zh)
|
1998-05-19 |
2006-04-05 |
阿维德克斯有限公司 |
可溶性t细胞受体
|
WO2000014257A1
(fr)
|
1998-09-04 |
2000-03-16 |
Sloan-Kettering Institute For Cancer Research |
Recepteurs de fusion specifiques a l'antigene prostatique specifique membranaire et ses utilisations
|
US6140081A
(en)
|
1998-10-16 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger binding domains for GNN
|
AU2472400A
(en)
|
1998-10-20 |
2000-05-08 |
City Of Hope |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
EP2275541B1
(fr)
|
1999-04-09 |
2016-03-23 |
Kyowa Hakko Kirin Co., Ltd. |
Procédé de contrôle de l'activité d'une molécule fonctionnelle immunologiquement
|
BR0010322A
(pt)
|
1999-05-06 |
2002-04-09 |
Univ Wake Forest |
Vetor de expressão, vacina e seu método de uso para eliciar uma resposta imune dirigida contra um antìgeno em um mamìfero
|
AU7950400A
(en)
|
1999-10-19 |
2001-04-30 |
Kyowa Hakko Kogyo Co. Ltd. |
Process for producing polypeptide
|
US20020061512A1
(en)
|
2000-02-18 |
2002-05-23 |
Kim Jin-Soo |
Zinc finger domains and methods of identifying same
|
US20030044787A1
(en)
|
2000-05-16 |
2003-03-06 |
Joung J. Keith |
Methods and compositions for interaction trap assays
|
US20020131960A1
(en)
|
2000-06-02 |
2002-09-19 |
Michel Sadelain |
Artificial antigen presenting cells and methods of use thereof
|
JP2002060786A
(ja)
|
2000-08-23 |
2002-02-26 |
Kao Corp |
硬質表面用殺菌防汚剤
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
JP4290423B2
(ja)
|
2000-10-06 |
2009-07-08 |
協和発酵キリン株式会社 |
抗体組成物を生産する細胞
|
US7064191B2
(en)
|
2000-10-06 |
2006-06-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Process for purifying antibody
|
JP5312721B2
(ja)
|
2000-11-07 |
2013-10-09 |
シティ・オブ・ホープ |
Cd19特異的再指向免疫細胞
|
EP1425039A4
(fr)
|
2001-03-23 |
2005-02-02 |
Us Gov Health & Human Serv |
Peptides immunoreactifs du papillomavirus humain
|
GB0108491D0
(en)
|
2001-04-04 |
2001-05-23 |
Gendaq Ltd |
Engineering zinc fingers
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
HUP0700103A3
(en)
|
2001-08-03 |
2012-09-28 |
Glycart Biotechnology Ag |
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
|
US20040224385A1
(en)
|
2001-08-20 |
2004-11-11 |
Barbas Carlos F |
Zinc finger binding domains for cnn
|
NZ531208A
(en)
|
2001-08-31 |
2005-08-26 |
Avidex Ltd |
Multivalent soluble T cell receptor (TCR) complexes
|
US20030157108A1
(en)
|
2001-10-25 |
2003-08-21 |
Genentech, Inc. |
Glycoprotein compositions
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
US20040093621A1
(en)
|
2001-12-25 |
2004-05-13 |
Kyowa Hakko Kogyo Co., Ltd |
Antibody composition which specifically binds to CD20
|
US20030170238A1
(en)
|
2002-03-07 |
2003-09-11 |
Gruenberg Micheal L. |
Re-activated T-cells for adoptive immunotherapy
|
WO2003085118A1
(fr)
|
2002-04-09 |
2003-10-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Procede de production de composition anticorps
|
PL373256A1
(en)
|
2002-04-09 |
2005-08-22 |
Kyowa Hakko Kogyo Co, Ltd. |
Cells with modified genome
|
CA2481925A1
(fr)
|
2002-04-09 |
2003-10-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Agent therapeutique pour les patients atteints du fc.gamma.riiia humain
|
CA2481656A1
(fr)
|
2002-04-09 |
2003-10-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Cellules dans lesquelles l'activite de la proteine impliquee dans le transport du gdp-fucose est reduite ou perdue
|
EP1500400A4
(fr)
|
2002-04-09 |
2006-10-11 |
Kyowa Hakko Kogyo Kk |
Medicament contenant une composition anticorps
|
EP1498491A4
(fr)
|
2002-04-09 |
2006-12-13 |
Kyowa Hakko Kogyo Kk |
Procede d'amelioration de l'activite d'une composition d'anticorps de liaison avec le recepteur fc gamma iiia
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
EP1549748B1
(fr)
|
2002-10-09 |
2014-10-01 |
Immunocore Ltd. |
Recepteurs de lymphocytes t de recombinaison a chaine unique
|
HU227217B1
(en)
|
2002-12-16 |
2010-11-29 |
Genentech Inc |
Immunoglobulin variants and uses thereof
|
US20050129671A1
(en)
|
2003-03-11 |
2005-06-16 |
City Of Hope |
Mammalian antigen-presenting T cells and bi-specific T cells
|
JPWO2005035586A1
(ja)
|
2003-10-08 |
2007-11-22 |
協和醗酵工業株式会社 |
融合蛋白質組成物
|
AU2004280065A1
(en)
|
2003-10-09 |
2005-04-21 |
Kyowa Hakko Kirin Co., Ltd. |
Process for producing antibody composition by using RNA inhibiting the function of alpha1,6-fucosyltransferase
|
US7435596B2
(en)
|
2004-11-04 |
2008-10-14 |
St. Jude Children's Research Hospital, Inc. |
Modified cell line and method for expansion of NK cell
|
MXPA06004836A
(es)
|
2003-11-05 |
2006-07-06 |
Glycart Biotechnology Ag |
Anticuerpos cd20 con funcion del efector y afinidad de enlace al receptor fc mejoradas.
|
WO2005053742A1
(fr)
|
2003-12-04 |
2005-06-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Medicament contenant une composition a base d'anticorps
|
AU2004308964B2
(en)
|
2003-12-23 |
2010-09-16 |
Arbor Vita Corporation |
Antibodies for oncogenic strains of HPV and methods of their use
|
DE602005022595D1
(de)
|
2004-06-29 |
2010-09-09 |
Immunocore Ltd |
Einen modifizierten t-zellen-rezeptor exprimierende zellen
|
NZ580115A
(en)
|
2004-09-23 |
2010-10-29 |
Genentech Inc |
Cysteine engineered antibody light chains and conjugates
|
AU2005291039A1
(en)
|
2004-10-01 |
2006-04-13 |
Avidex Ltd. |
T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents
|
JP2008044848A
(ja)
|
2004-11-30 |
2008-02-28 |
Univ Kurume |
Hla−a24拘束性腫瘍抗原ペプチド
|
US8252893B2
(en)
|
2005-01-31 |
2012-08-28 |
Board Of Trustees Of The University Of Arkansas |
CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
|
US8968995B2
(en)
|
2008-11-12 |
2015-03-03 |
Oncohealth Corp. |
Detection, screening, and diagnosis of HPV-associated cancers
|
US20100003704A1
(en)
|
2008-06-13 |
2010-01-07 |
Shuling Cheng |
IN SITU detection of early stages and late stages HPV infection
|
ES2398760T3
(es)
|
2007-03-30 |
2013-03-21 |
Memorial Sloan-Kettering Cancer Center |
Expresión constitutiva de ligandos coestimuladores en linfocitos T transferidos de forma adoptiva
|
ES2411059T3
(es)
|
2007-05-31 |
2013-07-04 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Epítopos de HPV objetivos de células T que infiltran malignidades cervicales para su uso en vacunas
|
US20090117140A1
(en)
|
2007-09-26 |
2009-05-07 |
Mayumi Nakagawa |
Human papilloma virus dominant CD4 T cell epitopes and uses thereof
|
ES2640216T3
(es)
|
2007-12-07 |
2017-11-02 |
Miltenyi Biotec Gmbh |
Sistemas y métodos para procesamiento de células
|
US8479118B2
(en)
|
2007-12-10 |
2013-07-02 |
Microsoft Corporation |
Switching search providers within a browser search box
|
KR20090103571A
(ko)
|
2008-03-28 |
2009-10-01 |
바이오코아 주식회사 |
면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련질환 예방 또는 치료용 조성물
|
US20120164718A1
(en)
|
2008-05-06 |
2012-06-28 |
Innovative Micro Technology |
Removable/disposable apparatus for MEMS particle sorting device
|
JP5173594B2
(ja)
|
2008-05-27 |
2013-04-03 |
キヤノン株式会社 |
管理装置、画像形成装置及びそれらの処理方法
|
KR20090125628A
(ko)
|
2008-06-02 |
2009-12-07 |
바이오코아 주식회사 |
면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련질환 예방 또는 치료용 조성물
|
KR20090125629A
(ko)
|
2008-06-02 |
2009-12-07 |
바이오코아 주식회사 |
면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련질환 예방 또는 치료용 조성물
|
SG10201609144RA
(en)
|
2008-08-22 |
2016-12-29 |
Sangamo Biosciences Inc |
Methods and compositions for targeted single-stranded cleavage and targeted integration
|
WO2010123561A1
(fr)
|
2009-04-20 |
2010-10-28 |
Arbor Vita Corporation |
Anticorps spécifiques pour les protéines e6 du papillomavirus humain (hpv) et leur utilisation
|
WO2011044186A1
(fr)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Récepteurs de lymphocytes t à chaîne unique humains
|
US9273283B2
(en)
|
2009-10-29 |
2016-03-01 |
The Trustees Of Dartmouth College |
Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
|
WO2011056894A2
(fr)
|
2009-11-03 |
2011-05-12 |
Jensen Michael C |
Récepteur du facteur de croissance de l'épiderme tronqué (egfrt) pour la sélection de lymphocytes t transduits
|
US8956828B2
(en)
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
EP2534163B1
(fr)
|
2010-02-09 |
2015-11-04 |
Sangamo BioSciences, Inc. |
Modification génomique ciblée avec des molécules donneuses partiellement monocaténaires
|
WO2011101122A1
(fr)
|
2010-02-16 |
2011-08-25 |
Österreichische Akademie der Wissenschaften |
Anticorps anti-hpv e7
|
US9228007B1
(en)
|
2010-03-11 |
2016-01-05 |
The Regents Of The University Of California |
Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells
|
EP3156062A1
(fr)
|
2010-05-17 |
2017-04-19 |
Sangamo BioSciences, Inc. |
Nouvelles protéines à liaison adn et leurs utilisations
|
KR101415554B1
(ko)
|
2010-09-13 |
2014-07-04 |
바이오코아 주식회사 |
면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련 질환 예방 또는 치료용 조성물
|
CA2814047C
(fr)
|
2010-10-08 |
2017-11-14 |
President And Fellows Of Harvard College |
Sequencage immunitaire a haut debit
|
CA2814049C
(fr)
|
2010-10-08 |
2021-07-13 |
President And Fellows Of Harvard College |
Etablissement a haut debit d'un code-barres de cellules simples
|
DK2649086T3
(en)
|
2010-12-09 |
2017-09-18 |
Univ Pennsylvania |
USING CHEMICAL ANTIGEN RECEPTOR-MODIFIED T-CELLS TO TREAT CANCER
|
CN103502438A
(zh)
|
2011-03-23 |
2014-01-08 |
弗雷德哈钦森癌症研究中心 |
用于细胞免疫治疗的方法和组合物
|
US8398282B2
(en)
|
2011-05-12 |
2013-03-19 |
Delphi Technologies, Inc. |
Vehicle front lighting assembly and systems having a variable tint electrowetting element
|
MX2014001222A
(es)
|
2011-07-29 |
2014-09-15 |
Univ Pennsylvania |
Receptores coestimuladores de cambio.
|
EP2567972A1
(fr)
|
2011-09-12 |
2013-03-13 |
Adriacell S.p.A. |
Anticorps contre la protéine E7 du virus du papillome humain
|
US9113616B2
(en)
|
2011-10-28 |
2015-08-25 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified mice having humanized TCR variable genes
|
AU2012335073B2
(en)
|
2011-11-11 |
2017-08-17 |
Fred Hutchinson Cancer Center |
Cyclin A1-targeted T-cell immunotherapy for cancer
|
WO2013074916A1
(fr)
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Lymphocytes t car+ génétiquement modifiés pour éliminer l'expression du récepteur des lymphocytes t et/ou le système hla
|
WO2013123061A1
(fr)
|
2012-02-13 |
2013-08-22 |
Seattle Children's Hospital D/B/A Seattle Children's Research Institute |
Récepteurs d'antigène chimères bispécifiques et utilisations thérapeutiques de ceux-ci
|
WO2013126726A1
(fr)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Lymphocytes t doubles transgéniques comportant un car et un tcr, et leurs procédés d'utilisation
|
RU2018130123A
(ru)
|
2012-05-03 |
2018-11-07 |
Фред Хатчинсон Кансэр Рисёч Сентер |
Клетка, экспрессирующая t-клеточный рецептор (tcr), для применения в клеточной иммунотерапии
|
EP2847338B1
(fr)
|
2012-05-07 |
2018-09-19 |
Sangamo Therapeutics, Inc. |
Procédés et compositions pour l'intégration médiée par nucléase de transgènes
|
EP2846816B1
(fr)
|
2012-05-08 |
2016-09-28 |
The Johns Hopkins University |
Méthodes et compositions pour la perfusion de populations choisies de lymphocytes allogéniques à prise de greffe transitoire pour traiter le cancer
|
SG11201407802WA
(en)
|
2012-05-25 |
2015-01-29 |
Cellectis |
Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy
|
PT2884999T
(pt)
|
2012-08-20 |
2021-01-05 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Método e composições para imunoterapêutica celular
|
MX370148B
(es)
|
2012-10-02 |
2019-12-03 |
Memorial Sloan Kettering Cancer Center |
Composiciones y su uso para inmunoterapia.
|
JP5372297B1
(ja)
|
2012-12-20 |
2013-12-18 |
三菱電機株式会社 |
車載装置及びプログラム
|
GB201223172D0
(en)
|
2012-12-21 |
2013-02-06 |
Immunocore Ltd |
Method
|
CA2902370C
(fr)
|
2013-02-26 |
2023-03-14 |
Memorial Sloan-Kettering Cancer Center |
Compositions et procedes d'immunotherapie
|
WO2014153470A2
(fr)
|
2013-03-21 |
2014-09-25 |
Sangamo Biosciences, Inc. |
Interruption ciblée de gènes de récepteur des lymphocytes t à l'aide de nucléases protéiques à doigt de zinc génétiquement modifiées
|
EP3730615A3
(fr)
|
2013-05-15 |
2020-12-09 |
Sangamo Therapeutics, Inc. |
Procédés et compositions pour le traitement d'une maladie génétique
|
ES2645393T3
(es)
|
2013-05-29 |
2017-12-05 |
Cellectis |
Métodos de manipulación de linfocitos T para inmunoterapia usando el sistema de nucleasa Cas guiada por ARN
|
RU2713333C2
(ru)
|
2013-07-15 |
2020-02-04 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Способы получения т-клеток против антигена папилломавируса человека
|
AU2014290288B2
(en)
|
2013-07-15 |
2018-03-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-human papillomavirus 16 E6 T cell receptors
|
CN103342738B
(zh)
|
2013-07-24 |
2015-02-18 |
广州恒上医药技术有限公司 |
人***瘤病毒e6蛋白可诱发同源蛋白间交叉反应性抗体的精细表位肽
|
JP5921042B2
(ja)
|
2013-07-30 |
2016-05-24 |
シャープ株式会社 |
光拡散部材の製造方法
|
EP3030900A2
(fr)
|
2013-08-08 |
2016-06-15 |
Institut Pasteur |
Corrélation entre une activité pathologique et des expansions clonales de cellules t cd8+ spécifiques du virus du papillome humain 16 chez des patients souffrant de lichens plans oraux érosifs sévères
|
US9108442B2
(en)
|
2013-08-20 |
2015-08-18 |
Ricoh Company, Ltd. |
Image forming apparatus
|
US20150098954A1
(en)
|
2013-10-08 |
2015-04-09 |
Elwha Llc |
Compositions and Methods Related to CRISPR Targeting
|
WO2015066551A2
(fr)
|
2013-10-31 |
2015-05-07 |
Fred Hutchinson Cancer Research Center |
Cellules effectrices non t, progénitrices et souches hématopoïétiques modifiées, et leurs utilisations
|
RU2752933C2
(ru)
|
2014-03-11 |
2021-08-11 |
Селлектис |
Способ создания т-клеток, пригодных для аллогенной трансплантации
|
WO2015143558A1
(fr)
|
2014-03-27 |
2015-10-01 |
British Columbia Cancer Agency Branch |
Identification d'épitopes de lymphocytes t
|
EP3132030B1
(fr)
|
2014-04-18 |
2020-08-26 |
Editas Medicine, Inc. |
Méthodes, compositions et constituants associés à crispr/cas pour l'immunothérapie du cancer
|
EP3134515B1
(fr)
|
2014-04-24 |
2019-03-27 |
Board of Regents, The University of Texas System |
Application de cellules souches pluripotentes induites pour générer des produits de thérapie cellulaire adoptive
|
CN106661098B
(zh)
*
|
2014-05-29 |
2021-05-04 |
美国卫生和人力服务部 |
抗人***瘤病毒16 e7的t细胞受体
|
BR112015015380A2
(pt)
|
2014-07-11 |
2017-07-11 |
Intel Corp |
dispositivos eletrônicos inclináveis e estiráveis e métodos
|
RU2751660C2
(ru)
|
2014-07-21 |
2021-07-15 |
Новартис Аг |
Лечение злокачественного новообразования с использованием гуманизированного химерного антигенного рецептора против всма
|
BR112017001818A2
(pt)
|
2014-07-29 |
2017-11-21 |
Pfizer |
receptores antigênicos quiméricos específicos para egfrviii para imunoterapia de câncer
|
WO2016022400A1
(fr)
|
2014-08-04 |
2016-02-11 |
Fred Hutchinson Cancer Research Center |
Immunothérapie par cellules t spécifiques de la wt-1
|
AU2015318011B2
(en)
|
2014-09-15 |
2020-07-23 |
Abvitro Llc |
High-throughput nucleotide library sequencing
|
GB201417803D0
(en)
|
2014-10-08 |
2014-11-19 |
Adaptimmune Ltd |
T cell receptors
|
KR20170075013A
(ko)
|
2014-10-31 |
2017-06-30 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Cart 세포에서 유전자 발현의 변경 및 그의 용도
|
JP6944876B2
(ja)
*
|
2015-03-16 |
2021-10-06 |
マックス−デルブリュック−ツェントルム フューア モレキュラーレ メディツィン イン デア ヘルムホルツ−ゲマインシャフト |
Mhc細胞ライブラリーを用いる、新規の免疫原性t細胞エピトープの検出方法および新規の抗原特異的t細胞受容体の単離方法
|
EP3294328A1
(fr)
|
2015-05-08 |
2018-03-21 |
Eureka Therapeutics, Inc. |
Constructions ciblant les complexes mhc/peptide hpv16-e7 et leurs utilisations
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
CN108024544B
(zh)
|
2015-07-13 |
2022-04-29 |
桑格摩生物治疗股份有限公司 |
用于核酸酶介导的基因组工程化的递送方法及组合物
|
US11047011B2
(en)
|
2015-09-29 |
2021-06-29 |
iRepertoire, Inc. |
Immunorepertoire normality assessment method and its use
|
DK3756682T3
(da)
|
2015-10-05 |
2022-07-11 |
Prec Biosciences Inc |
Genetisk modificerede celler, der omfatter et modificeret gen fra det konstante område af den humane t-cellereceptor alpha
|
EP3156067A1
(fr)
*
|
2015-10-16 |
2017-04-19 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Récepteurs de lymphocytes t hpv à avidité élevée
|
WO2017070429A1
(fr)
|
2015-10-22 |
2017-04-27 |
Regents Of The University Of Minnesota |
Procédés consistant à éditer des polynucléotides codant pour un récepteur de lymphocytes t
|
JP6777841B2
(ja)
|
2015-10-23 |
2020-10-28 |
国立大学法人金沢大学 |
細胞傷害性t細胞の作製方法
|
IL259576B
(en)
|
2015-12-04 |
2022-09-01 |
Novartis Ag |
grna molecule containing tracr and crrna, pharmaceutical composition containing it and method for preparing cells for immunotherapy
|
AU2016369490C1
(en)
|
2015-12-18 |
2021-12-23 |
Sangamo Therapeutics, Inc. |
Targeted disruption of the T cell receptor
|
GB201604494D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers
|
GB201604953D0
(en)
|
2016-03-23 |
2016-05-04 |
Immunocore Ltd |
T cell receptors
|
IL262144B2
(en)
|
2016-04-08 |
2024-04-01 |
Immunocore Ltd |
T cell receptors
|
IL302641A
(en)
|
2016-05-06 |
2023-07-01 |
Juno Therapeutics Inc |
Genetically engineered cells and methods for their preparation
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
CA3028002A1
(fr)
|
2016-06-27 |
2018-01-04 |
Juno Therapeutics, Inc. |
Procede d'identification d'epitopes peptidiques, molecules qui se lient a de tels epitopes et utilisations associees
|
EP3494132A4
(fr)
|
2016-08-03 |
2020-03-18 |
Washington University |
Édition génétique des cellules car-t pour le traitement de malignités des lymphocytes t avec des récepteurs d'antigènes chimériques
|
US9642906B2
(en)
|
2016-09-16 |
2017-05-09 |
Baylor College Of Medicine |
Generation of HPV-specific T-cells
|
KR20190062505A
(ko)
|
2016-10-03 |
2019-06-05 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Hpv-특이적 결합 분자
|
WO2018073393A2
(fr)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Cellules allogéniques modifiées par une nucléase d'effecteur tal (talen) appropriées pour une thérapie
|
US11944643B2
(en)
|
2017-03-31 |
2024-04-02 |
Cellectis Sa |
Universal anti-CD22 chimeric antigen receptor engineered immune cells
|
EP3634493A1
(fr)
|
2017-05-08 |
2020-04-15 |
Precision BioSciences, Inc. |
Molécules d'acide nucléique codant pour un récepteur d'antigène modifié et molécule d'acide nucléique inhibitrice et leurs méthodes d'utilisation
|
WO2019097305A2
(fr)
|
2017-05-12 |
2019-05-23 |
Crispr Therapeutics Ag |
Matériaux et procédés de génie cellulaire et leurs utilisations en immuno-oncologie
|
EP3645562A1
(fr)
|
2017-06-28 |
2020-05-06 |
Regeneron Pharmaceuticals, Inc. |
Protéines de liaison à l'antigène anti-papillomavirus humain et leurs méthodés d'utilisation
|
CA3068465A1
(fr)
|
2017-06-30 |
2019-01-03 |
Precision Biosciences, Inc. |
Lymphocytes t genetiquement modifies comprenant un intron modifie dans le gene alpha du recepteur des lymphocytes t
|
MX2020004185A
(es)
*
|
2017-09-27 |
2021-01-08 |
Univ Southern California |
Nuevas plataformas para coestimulacion, nuevos diseños car y otras mejoras para terapia celular adoptiva.
|
MA52207A
(fr)
|
2018-04-05 |
2021-02-17 |
Editas Medicine Inc |
Lymphocytes t exprimant un récepteur recombinant, polynucléotides et procédés associés
|
WO2019195492A1
(fr)
|
2018-04-05 |
2019-10-10 |
Juno Therapeutics, Inc. |
Procédés de production de cellules exprimant un récepteur recombinant et compositions associées
|
EP3773908A1
(fr)
|
2018-04-05 |
2021-02-17 |
Juno Therapeutics, Inc. |
Récepteurs de lymphocytes t et cellules modifiées les exprimant
|